NeoGenomics Inc (NEO)
15.39
+0.03
(+0.20%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Total Assets (Quarterly): 1.641B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.641B |
| June 30, 2024 | 1.643B |
| March 31, 2024 | 1.640B |
| December 31, 2023 | 1.681B |
| September 30, 2023 | 1.678B |
| June 30, 2023 | 1.695B |
| March 31, 2023 | 1.709B |
| December 31, 2022 | 1.740B |
| September 30, 2022 | 1.756B |
| June 30, 2022 | 1.792B |
| March 31, 2022 | 1.830B |
| December 31, 2021 | 1.870B |
| September 30, 2021 | 1.906B |
| June 30, 2021 | 1.896B |
| March 31, 2021 | 1.494B |
| December 31, 2020 | 988.33M |
| September 30, 2020 | 959.43M |
| June 30, 2020 | 945.48M |
| March 31, 2020 | 732.25M |
| December 31, 2019 | 709.51M |
| September 30, 2019 | 711.16M |
| June 30, 2019 | 696.67M |
| March 31, 2019 | 533.34M |
| December 31, 2018 | 505.02M |
| September 30, 2018 | 455.14M |
| Date | Value |
|---|---|
| June 30, 2018 | 345.78M |
| March 31, 2018 | 349.27M |
| December 31, 2017 | 344.45M |
| September 30, 2017 | 343.90M |
| June 30, 2017 | 339.88M |
| March 31, 2017 | 343.64M |
| December 31, 2016 | 337.12M |
| September 30, 2016 | 355.43M |
| June 30, 2016 | 351.56M |
| March 31, 2016 | 346.84M |
| December 31, 2015 | 351.29M |
| September 30, 2015 | 83.74M |
| June 30, 2015 | 82.97M |
| March 31, 2015 | 81.16M |
| December 31, 2014 | 81.11M |
| September 30, 2014 | 78.82M |
| June 30, 2014 | 43.64M |
| March 31, 2014 | 42.32M |
| December 31, 2013 | 39.92M |
| September 30, 2013 | 35.23M |
| June 30, 2013 | 34.46M |
| March 31, 2013 | 33.62M |
| December 31, 2012 | 30.07M |
| September 30, 2012 | 29.30M |
| June 30, 2012 | 28.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
709.51M
Minimum
Dec 2019
1.906B
Maximum
Sep 2021
1.515B
Average
1.680B
Median
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 6.113B |
| Henry Schein Inc | 10.60B |
| Karyopharm Therapeutics Inc | 189.48M |
| Apellis Pharmaceuticals Inc | 901.87M |
| Beam Therapeutics Inc | 1.171B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 732.90M |
| Shareholders Equity (Quarterly) | 908.21M |
| Debt to Equity Ratio | 0.595 |
| Current Ratio | 1.991 |
| Net Debt Paydown Yield | -0.04% |